ArticleJMIR aging2025
Implementation of an Electronic Medication Management System in 41 Residential Care Homes in Hong Kong: Pre-Post Interventional Study.
Article in JMIR aging, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The medication management process in resident care homes for the elderly (RCHEs) is complex and can be labor intensive. In 2019, a nongovernment organization led by pharmacists with special interest in informatics developed the SafeMed Medication Management System (SMMS), which is a digital web-based system that integrates electronic medical profiles and medication profiles to revamp the traditional manual medication management process in RCHEs in Hong Kong. Objective: This study aimed to assess the effectiveness of the SMMS in improving RCHE staff's time efficiency and competencies in the medication management process and how this could potentially reduce human resource costs after its implementation. Methods: This was a pre-post interventional study conducted from September 2022 to August 2024. Time efficiency was evaluated using time-motion analysis. The time spent on each process-preparing the medication doses, checking the prepared doses, and administering the doses to residents-was evaluated in 10-minute blocks. The mean numbers of doses prepared, checked, and administered were calculated for each block. A three-way ANOVA was used to compare the doses before and after the system implementation. Staff competencies and perceived acceptance of the system were evaluated using a structured survey adapted from the technology acceptance model. An exploratory analysis was conducted to estimate the potential financial savings attributable to SMMS implementation using RCHE staff salary data obtained from publicly available governmental sources. Results from the time-motion analysis were used to estimate the cost per dose prepared by RCHE staff before and after the system implementation. Results: Forty-one RCHEs implemented the SMMS, serving a total of 3911 residents. The time-motion analysis (n=6 RCHEs) revealed that the mean (SD) number of doses significantly increased in 10-minute blocks after system implementation (medication preparation: 25, SD 14 to 49, SD 15 doses; medication checking: 21, SD 6 to 85, SD 33 doses; medication administration: 9, SD 1 to 16, SD 6 doses). The overall mean number of doses handled across all processes combined was significantly higher after implementation (18.9 vs 51.9 doses, P=.02). RCHE staff (n=392) reported significantly improved competencies in entering and accessing residents' records and preparing, checking, and administering medications after the system implementation (all P<.001). The estimated cost of managing one dose of medication dropped substantially from HKD 2.00 (US $0.25) before to HKD 0.74 (US $0.09) after system implementation. If fully implemented in all RCHEs across Hong Kong, the daily human resource cost associated with the medication management process could potentially be reduced from HKD 2,574,000 (US $330,000) to HKD 952,380 (US $122,100). Conclusions: The time-motion analysis and quantitative survey findings suggest that digital technology combined with automation can improve staff's time efficiency and competencies and promote human resource cost-saving in the medication management process. Future work should evaluate the long-term impact of this system on medication safety and its cost-effectiveness in RCHEs.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.